July 31, 2019Open Access
Association of Biologic Therapy With Coronary Inflammation in Patients With Psoriasis as Assessed by Perivascular Fat Attenuation Index
Structured PICO
Does biologic therapy reduce coronary inflammation assessed by perivascular FAI in patients with moderate to severe psoriasis?
P
Population
Patients with moderate to severe psoriasis
I
Intervention
Biologic therapy
O
Outcome
Coronary inflammation assessed by perivascular fat attenuation index (FAI) measured by CCTAsurrogate
Biologic therapy in psoriasis patients is associated with reduced coronary inflammation, suggesting perivascular FAI via CCTA could track responses to interventions for coronary artery disease.
Abstract
In this study, biologic therapy for moderate to severe psoriasis was associated with reduced coronary inflammation assessed by perivascular FAI. This finding suggests that perivascular FAI measured by CCTA may be used to track response to interventions for coronary artery disease.
Connected Papers
Building similarity graph...
Analyzing shared references across papers
Discussion
Loading...
Authors
Y
Youssef Elnabawi
Cornell University
Evangelos K. Oikonomou
Cardiac Imaging
A
Amit K. Dey
University of Kalyani
Journals
JAMA Cardiology
Actions
Institutions
National Institutes of Health
University of Oxford
University of Pennsylvania
References and Citations
Connected Papers
Building similarity graph...
Analyzing shared references across papers
Discussion
Loading...